170 related articles for article (PubMed ID: 32101973)
1. Drug Enforcement Agency 2014 Hydrocodone Rescheduling Rule and Opioid Dispensing after Surgery.
Neuman MD; Hennessy S; Small DS; Newcomb C; Gaskins L; Brensinger CM; Wijeysundera DN; Bateman BT; Wunsch H
Anesthesiology; 2020 May; 132(5):1151-1164. PubMed ID: 32101973
[TBL] [Abstract][Full Text] [Related]
2. Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.
Habbouche J; Lee J; Steiger R; Dupree JM; Khalsa C; Englesbe M; Brummett C; Waljee J
JAMA Surg; 2018 Dec; 153(12):1111-1119. PubMed ID: 30140896
[TBL] [Abstract][Full Text] [Related]
3. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach.
Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat M; Sawant RV; Ferries E; Reeve K; Todd KH
Res Social Adm Pharm; 2017; 13(3):503-512. PubMed ID: 27567741
[TBL] [Abstract][Full Text] [Related]
4. Decline in opioid prescribing after federal rescheduling of hydrocodone products.
Raji MA; Kuo YF; Adhikari D; Baillargeon J; Goodwin JS
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):513-519. PubMed ID: 29271049
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
[TBL] [Abstract][Full Text] [Related]
6. Has the rescheduling of hydrocodone changed ED prescribing practices?
Oehler EC; Day RL; Robinson DB; Brown LH
Am J Emerg Med; 2016 Dec; 34(12):2388-2391. PubMed ID: 27776785
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
[TBL] [Abstract][Full Text] [Related]
8. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population.
Tran S; Lavitas P; Stevens K; Greenwood BC; Clements K; Alper CJ; Lenz K; Price M; Hydery T; Arnold JL; Takeshita M; Bacon R; Peristere JP; Jeffrey PL
J Manag Care Spec Pharm; 2017 May; 23(5):532-539. PubMed ID: 28448772
[TBL] [Abstract][Full Text] [Related]
9. Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation.
Liaw V; Kuo YF; Raji MA; Baillargeon J
Public Health Rep; 2020 Jan; 135(1):114-123. PubMed ID: 31835012
[TBL] [Abstract][Full Text] [Related]
10. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
[TBL] [Abstract][Full Text] [Related]
11. The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures.
Mallama C; Karami S; Zhang D; Zhao Y; Yang Y; Woods C; Ding Y; Meyer T; McAninch J
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5793. PubMed ID: 38783553
[TBL] [Abstract][Full Text] [Related]
12. Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences.
Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat MA; Varisco TJ; Pickard T; Reeve K; Todd KH
J Pain Palliat Care Pharmacother; 2019; 33(1-2):22-31. PubMed ID: 31454279
[TBL] [Abstract][Full Text] [Related]
13. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014.
Fischer LJ; Severtson SG; Gurrola MC; Iwanicki JL; Green JL; Dart RC
Subst Use Misuse; 2022; 57(7):1097-1103. PubMed ID: 35450512
[TBL] [Abstract][Full Text] [Related]
14. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
[TBL] [Abstract][Full Text] [Related]
15. Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study.
Fernandez J; Thornton JD; Rege S; Lewing B; Bapat S; Xu Q; Fleming ML
J Opioid Manag; 2018; 14(5):317-326. PubMed ID: 30387855
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Usmani SA; Hollmann J; Goodin A; Hincapie-Castillo JM; Adkins LE; Ourhaan N; Oueini R; Bhagwandass H; Easey T; Vouri SM
J Am Pharm Assoc (2003); 2021; 61(2):e20-e44. PubMed ID: 33127312
[TBL] [Abstract][Full Text] [Related]
17. Impact of hydrocodone reclassification on analgesic prescribing in the Veterans Health Administration.
Steckler TJ; Mosher HJ; Desloover-Koch Y; Lund BC
Am J Health Syst Pharm; 2019 May; 76(Supplement_2):S61-S67. PubMed ID: 30873558
[TBL] [Abstract][Full Text] [Related]
18. Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone users.
Murimi IB; Chang HY; Bicket M; Jones CM; Alexander GC
Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):70-79. PubMed ID: 30187574
[TBL] [Abstract][Full Text] [Related]
19. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.
Wu A; Phan C; Nguyen KC; Quindoy M; Lewis J; Apollonio DE
Clin Toxicol (Phila); 2021 Apr; 59(4):313-319. PubMed ID: 32840386
[TBL] [Abstract][Full Text] [Related]
20. Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio.
Liu Y; Baker O; Schuur JD; Weiner SG
Pain Med; 2020 Sep; 21(9):1863-1870. PubMed ID: 31502638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
